TrialJournal of cancer research and clinical oncology2023

Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma.

Jiehui Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.